|
|
||||||||
Ann Thorac Surg 2006;82:1400-1405
© 2006 The Society of Thoracic Surgeons
a Section of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, Connecticut
b Department of Genetics, Yale University School of Medicine, New Haven, Connecticut
Accepted for publication April 19, 2006.
* Address correspondence to Dr Elefteriades, 121 FMB, 333 Cedar St, New Haven, CT 06510 (Email: john.elefteriades{at}yale.edu).
Presented at the Poster Session of the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30Feb 1, 2006.
| Abstract |
|---|
|
|
|---|
METHODS: Interviews were conducted with 520 patients with TAAs and their pedigrees were compiled to identify family members with aneurysms. Study patients were divided into three groups: 101 non-Marfan patients, in 88 pedigrees, had a family pattern for TAA (familial group), 369 had no family pattern (sporadic group), and 50 had Marfan syndrome (MFS). We determined incidence of familial clustering, age at presentation, rate of aneurysm growth, incidence of hypertension, correlation of aneurysm sites among kindred, and pedigree inheritance patterns.
RESULTS: An inherited pattern for TAA was present in 21.5% of non-MFS patients. The predominant inheritance pattern was autosomal dominant (76.9%), with varying degrees of penetrance and expressivity. The familial TAA group was significantly younger than the sporadic group (p < 0.0001), but not as young as the MFS group (p < 0.0001) (mean ages, 58.2 versus 65.7 versus 27.4 years). Among all 197 probands and kindred with aneurysm, 131 (66.5%) had TAA, 49 (24.9%) had abdominal aortic aneurysm (AAA), and 17 (8.6%) had cerebral or other aneurysms. Ascending aneurysm paired most commonly with ascending, and descending with abdominal. Abdominal aortic aneurysms (AAAs) and hypertension were more often associated with descending than with ascending TAAs (p < 0.001). Aortic growth rate was highest for the familial group (0.21cm/y), intermediate for the sporadic group (0.16 cm/y), and lowest for the Marfan group (0.1 cm/y; p < 0.01).
CONCLUSIONS: TAAs are frequently familial diseases. The predominant mode of inheritance is autosomal dominant. Familial TAAs have a relatively early age of onset. Aneurysms in relatives may be seen in the thoracic aorta, the abdominal aorta, or the cerebral circulation. Screening of first-order relatives of probands with TAA is essential. Familial TAAs tend to grow at a higher rate, exemplifying a more aggressive clinical entity.
| Introduction |
|---|
|
|
|---|
Rapid advances are being made in the understanding of TAA disease at the molecular genetic level. In pedigrees with several generations of multiply affected family members, chromosomal loci have been identified that relate to the TAA phenotype by using the methods of linkage analysis and gene sequencing. Thus far, these loci have been mapped to the 5q13-14, 11q 23.2-24, and 3p24-25 chromosome sites [57]. Most recently, important work by Pannu and colleagues [8] has localized the mutation on the 3p24-25 chromosome to the transforming growth factor-ß receptor type II. As these advances in molecular genetics continue, it remains important to evaluate the clinical patterns of genetic transmission of thoracic aortic aneurysm in large populations. That is the goal of the present investigation.
| Material and Methods |
|---|
|
|
|---|
The interviewees consented to be interviewed. Selection of patients for interview was essentially random and not based on any clinical patient characteristics. Interviewers tended to select for contact, from the overall lists they were provided, patients recently seen rather than remotely seen, with regards to the time of interview. The labor-intensive interview process was conducted episodically over nearly 10 years, however, so we did not anticipate significant selection bias, temporal or other. Among all patients in all groups, 22% had presented to Yale or to another institution with a complication (rupture or dissection), and the rest were diagnosed after an imaging study.
When a proband reported a positive family history for aneurysm disease or sudden cardiac death, detailed investigations were undertaken to determine if the suspect family member(s) indeed harbored aneurysms. With few exceptions, the kindred's having an aortic aneurysm was confirmed either by direct interview of the kindred, by obtaining a corroborating imaging study, or by verifying surgery for correction of an aortic aneurysm. Merely anecdotal cases were excluded. Family screening was strongly recommended but was not performed as a formal part of this study. When family members were screened at their local centers, the results were forwarded to us by the proband and incorporated into our spreadsheets.
No evidence of a named syndromic connective tissue disorder was found in 470 of the 520 patients, and 50 were classified as having Marfan syndrome (MFS) in accordance with the Gent criteria [9]. The evaluation for Marfan disease was done by the surgical team, with formal genetic consultation only when the clinical picture appeared ambiguous. Of the non-Marfan patients, 101 exhibited familial clustering of TAAs (familial group), and 369 had no family member with TAA (sporadic group). In the familial group, 23 patients had a relative who was also a proband in the group, resulting in 88 separate familial pedigrees. See Figure 1 for a patient flow diagram.
|
In 73 of the 88 familial pedigrees, a correlation was possible between the site of the TAA in the proband, either ascending or descending, and the site of the arterial aneurysms among their kindred, including TAAs, abdominal aortic aneurysms (AAAs), and cerebral arterial aneurysms. In the remaining 15 pedigrees, a family member was known to have had an aneurysm, but the aneurysm site was unknown and could not be determined.
The presence of antecedent hypertension was determined in 74 familial pedigrees, permitting analysis of the difference in prevalence between ascending and descending TAA involvement by using the nondirectional Yates
2 analysis.
Rates of aneurysm growth for 160 non-Marfan probands (31 familials and 129 sporadics) were calculated from the change in the measured aneurysm size on successive imaging studies. The method for calculating this rate of growth was published earlier [10]. The rate of growth of 39 MFS patients analyzed in our prior study is included in the analysis. The mode of inheritance is described for the 88 familial pedigrees and confirmed by a clinical geneticist (MR).
| Results |
|---|
|
|
|---|
Sex of Probands
Males predominated in the three groups. This was most pronounced in the familial group (2.5:1) and least in the MFS group (1.6:1).
Age at Presentation
A statistically significant difference was noted in the mean age at presentation among the three groups studied. Age at presentation refers either to the age at which a symptomatic patient presented with a complication or the age at which an asymptomatic patient had an incidental finding of aneurysm on radiographic imaging. The MFS patients were significantly younger than the familial group (27.4 years versus 55.4 years, p < 0.0001), and the familial group was significantly younger than the sporadic group (58.2 years versus 65.7 years; p < 0.0001).
Nature and Anatomic Location of Aneurysm Disease
For the 520 patients in the three study groups, the ascending aorta was affected with an aneurysm or dissection in 413 cases (79.4%) and the descending aorta in 107 cases (20.6%). Arch aneurysms cases were grouped with the portion of the aorta, ascending or descending, most closely related anatomically to the arch aneurysm.
For the familial group, 63 (79.7%) of 79 ascending aortas affected had aneurysms and 16 (20.3%) had dissections. Of 22 descending aortas, an equal number (11, 50%) were affected with aneurysms as with dissections.
For the sporadic group, 235 (82.1%) of 287 ascending aortas affected had aneurysms and 52 (17.9%) had dissections. Of 82 descending aortas affected, 43 (52.5%) had aneurysms and 39 (47.5%) had dissections.
For the MFS group, 41 (87.2%) of 47 ascending aortas affected had aneurysms and 6 (12.8%) had dissections. Of 3 descending aortas, all were affected with dissections.
For the three groups, the presented data reveals that the proportion of dissections in the descending aorta was significantly greater than in the ascending (familial, p < 0.05; sporadic, p < 0.0005; MFS, p < 0.005)
Rate of Aneurysm Growth
Growth rate determinations were done using two measurements for each patient, determined a mean of 21 months apart. The weighted average rate of growth was 0.21 cm/y for 31 familial probands, 0.16 cm/y for 129 sporadics, and 0.10 cm/y for 39 Marfan patients (p < 0.01; Fig 2).
|
|
|
It was seen that the pairing of ascending TAAs with ascending TAAs, 90 (60.8%) of 148 pairs, was significantly more common than for descending TAAs with ascending TAAs, 7 (15.6%) of 45 pairs (p < 0.0001). Similarly, it was seen that the pairing of descending TAAs with AAAs, 27 (60.0%) of 45 paired sites, was significantly more common than for ascending TAAs and AAAs, 34 (30.0%) of 148 paired sites (p < 0.0001), using the nondirectional Yates
2 method. As can be seen in Figure 4, the kindred could harbor the aneurysm in any site, but ascending paired most commonly with ascending and descending paired most commonly with AAA.
Hypertension in Ascending Versus Descending Thoracic Aortic Aneurysms
Of 74 probands and kindred in the familial group for whom a history of antecedent hypertension could be ascertained, a statistically higher prevalence was found among patients with descending TAAs, 13 (86.7%) of 15, compared with patients with ascending TAAs, 15 (25.4%) of 59 (p < 0.001), using the nondirectional Yates
2 method (Fig 5).
|
| Comment |
|---|
|
|
|---|
The thrust of this investigation argues strongly that all first-order family members of patients with aneurysms of any type should be screened for TAA and AAA. We use cardiac echocardiography for younger individuals (age < 40) and echocardiography plus computed tomography (CT) scans or magnetic resonance imaging (MRI) of the chest and abdomen for the older group. We screen siblings, parents, grandparents, children, and grandchildren, as well as more distant relatives in highly affected families.
Additional commentary is warranted on several of these observations.
The predominant mode of inheritance for our TAA pedigrees is autosomal dominant, an inheritance mode that is best explained by the transmission of a gene(s) encoding for a protein that affects the vascular wall integrity. We also found reduced penetrance and variable expressivity as well as multiple anatomic locations of familial arterial aneurysms, consistent with other studies of the inheritance pattern of TAAs [18]. The decreased penetrance, however, gives rise to the possibility of noninclusion of affected family members owing to a lack of overt clinical signs.
Indeed, it is quite likely that the true rate of inheritance of TAA is even higher than this study indicates. To be counted as affected in this study, a family member needed to have a known aneurysm. Many family members of our probands may well have harbored an aneurysm but simply not have been diagnosed or aware. An additional cause for noninclusion was the relatively advanced age of onset of aneurysm formation, so that younger patients harboring the preclinically overt TAA phenotype may have also been underdiagnosed [18].
Our finding in this large series that more than 20% of TAAs occur with familial clustering is a result that has remained remarkably constant, because our series of analyzed patients has increased and accords with results from other series. This statistic certainly underestimates the true prevalence of aneurysm disease in kindred, however, because many family members may harbor unknown aneurysms. A limitation of this study is that it is based on interviews and not on routine radiographic screenings of family members. Another limitation is that only a fraction of all the patients in our database underwent the labor-intensive patient and family interviews.
We have a program currently underway for screening family members of probands with thoracic aortic aneurysm by two-dimensional ultrasound scans of the thoracic and abdominal aortas. This study should approach the true incidence of familial inheritance of this disease more closely and is essential for accurately phenotyping affected family members for the purpose of linkage analysis. Simultaneously, we are performing genome-wide screening of a large cohort of patients that may identify specific genetic mutations for this known genetically heterogeneous disorder [22].
Although there is much additional genetic clarification to be done, we believe the present study, with a wealth of clinical information in a large cohort of patients, clearly confirms the genetic nature of thoracic aortic aneurysm and dissection. We look forward to the day when complete identification of errant genes has been accomplished and specific blood tests can be developed for clinical screening purposes.
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
H. K. Song, J. E. Bavaria, M. W. Kindem, K. W. Holmes, D. M. Milewicz, C. L. Maslen, R. E. Pyeritz, C. T. Basson, K. Eagle, H. E. Tolunay, et al. Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. Ann. Thorac. Surg., September 1, 2009; 88(3): 781 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Patel and G. M. Deeb Ascending and Arch Aorta: Pathology, Natural History, and Treatment Circulation, July 8, 2008; 118(2): 188 - 195. [Full Text] [PDF] |
||||
![]() |
M. G. Keane and R. E. Pyeritz Medical Management of Marfan Syndrome Circulation, May 27, 2008; 117(21): 2802 - 2813. [Full Text] [PDF] |
||||
![]() |
H. Kuivaniemi, C. D. Platsoucas, and M. D. Tilson III Aortic Aneurysms: An Immune Disease With a Strong Genetic Component Circulation, January 15, 2008; 117(2): 242 - 252. [Full Text] [PDF] |
||||
![]() |
T. B. Reece, R. R. Singh, B. M. Stiles, B. B. Peeler, J. A. Kern, C. G. Tribble, and I. L. Kron Replacement of the Proximal Aorta Adds No Further Risk to Aortic Valve Procedures Ann. Thorac. Surg., August 1, 2007; 84(2): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bridges Invited commentary. Ann. Thorac. Surg., October 1, 2006; 82(4): 1405 - 1406. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |